About Us
Premier ACO Physicians Network, LLC
Previous Names: N/A
ATTN: Value Based Programs
14201 Dallas Parkway
Dallas, TX 75254
ACO Primary Contact
Primary Contact Name | Rodney Farrar |
---|---|
Primary Contact Phone Number | (469) 893-2730 |
Primary Contact Email Address | PremierACO@tenethealth.com |
Organizational Information
ACO Participants:
ACO Participants | ACO Participant in Joint Venture |
---|---|
Ajay G. Meka, M.D., Inc. | N |
Alicia G Nugas, M.D., Inc. | N |
Dr. Linda Hsu, A Professional Corp. | N |
Good Life Medical Group, Inc. | N |
Harold W. Seifer, M.D. & Michael Freund, M.D., Inc. | N |
Joseph Au, M.D. | N |
Julie Sherman | N |
Loan T Truong, M.D., Inc | N |
Loida P Constantino, M.D. Inc | N |
Prohealth Partners, A Medical Group | N |
Reginald Yeske, M.D. | N |
Robby T Ayoub, M.D. Prof Medical Corp | N |
Robert Melikian, M.D. | N |
Srividya Venkataraman, M.D., Inc. | N |
St John Medical Group, Inc | N |
Wellcare Medical Group | N |
ACO Governing Body:
Member Last Name |
Member First Name |
Member Title/Position |
Member's Voting Power: expressed as a percentage or number | Membership Type | ACO Participant Legal Business Name/DBA, if applicable |
---|---|---|---|---|---|
Shah | Mansoor | Board Chair | 8.33% | ACO Participant Rep | ProHealth Partners |
Saeed | Khalid | Phys Board Member | 8.33% | ACO Participant Rep | ProHealth Partners |
DeJong | Clayton | Phys Board Member | 8.33% | ACO Participant Rep | ProHealth Partners |
Allswang | Barry | Phys Board Member | 8.33% | ACO Participant Rep | ProHealth Partners |
Yeske | Reginald | Phys Board Member | 8.33% | ACO Participant Rep | Reginal Yeske, MD |
Licuanan | Jessee | Phys Board Member | 8.33% | ACO Participant Rep | ProHealth Partners |
Chung | Winston | Phys Board Member | 8.33% | ACO Participant Rep | ProHealth Partners |
Ayoub | Robby | Phys Board Member | 8.33% | ACO Participant Rep | Robby T Ayoub MD Prof Medical Corp |
Hugh | Peter | Phys Board Member | 8.33% | ACO Participant Rep | Good Life Medical Group, Inc |
Venkataraman | Srividiya | Phys Board Member | 8.33% | ACO Participant Rep | Srividiya Venkataraman, MD, Inc |
Maison | Beverly | Board Member | 8.33% | Facility Participant Rep | N/A |
Soni | Viney | Board Member | 8.33% | Medicare Beneficiary | N/A |
Constanza | Donna | Community Stakeholder | 0% | Facility Participant Rep | N/A |
Boullon | Rob | Community Stakeholder | 0% | ACO Participant Rep | ProHealth Partners |
Key ACO clinical and administrative leadership:
- ACO Executive: Rodney Farrar
- Medical Director: Khalid Saeed
- Compliance Officer: Stephanie Carpenter
- Quality Assurance/Improvement Officer: Rodney Farrar
Associated committees and committee leadership:
Committee Name | Committee Leader Name and Position |
---|---|
N/A | N/A |
Types of ACO participants, or combinations of participants, that formed the ACO:
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses:
- Third Agreement Period
- Performance Year 2020, $2,607,236
- Performance Year 2019, $1,031,362
- Second Agreement Period
- Performance Year 2019, $1,031,362
- Performance Year 2018, $2,642,280
- Performance Year 2017, $0
- Performance Year 2016, $0
- First Agreement Period
- Performance Year 2015, $0
- Performance Year 2014, $0
- Performance Year 2013, $0
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Shared Savings Distribution:
- Third Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2019
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2018
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources N/A
- Proportion of distribution to ACO participants: N/A
- First Agreement Period
- Performance Year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2014
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2013
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
- Performance Year 2019
- Performance Year 2020
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Quality Performance Results
2020 Quality Performance Results:
ACO # | Measure Name | Rate | ACO Mean |
---|---|---|---|
ACO8 | Risk-Standardized,All Condition Readmission | 15.54 | 15.07 |
ACO38 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions | 48.23 | 49.50 |
ACO43 | Ambulatory Sensitive Condition Acute Composite | 0.61 | 0.95 |
ACO13 | Falls: Screening for Future Fall Risk | 57.71 | 84.97 |
ACO14 | Preventive Care and Screening: Influenza Immunization | 54.39 | 76.03 |
ACO17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 75.00 | 81.67 |
ACO18 | Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan | 46.37 | 71.46 |
ACO19 | Colorectal Cancer Screening | 67.85 | 72.59 |
ACO20 | Breast Cancer Screening | 73.32 | 74.05 |
ACO42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 74.96 | 83.37 |
ACO27 | Diabetes: Hemoglobin A1c Poor Control (>9%) | 19.31 | 14.70 |
ACO28 | Controlling High Blood Pressure | 71.97 | 72.87 |
* Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
- Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.